These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 9758339)

  • 1. Phase II study of high-dose thiotepa and hematopoietic stem cell transplantation in children with solid tumors.
    Lucidarme N; Valteau-Couanet D; Oberlin O; Couanet D; Kalifa C; Beaujean F; Lapierre V; Hartmann O
    Bone Marrow Transplant; 1998 Sep; 22(6):535-40. PubMed ID: 9758339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-dose thiotepa and hematopoietic stem cell transplantation in pediatric malignant mesenchymal tumors: a phase II study.
    Lafay-Cousin L; Hartmann ; Plouvier P; Méchinaud F; Boutard P; Oberlin O
    Bone Marrow Transplant; 2000 Sep; 26(6):627-32. PubMed ID: 11035368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-dose sequential chemotherapy and autologous stem cell reinfusion in advanced pediatric solid tumors.
    Chan KW; Petropoulos D; Choroszy M; Herzog C; Jaffe N; Ater J; Korbling M
    Bone Marrow Transplant; 1997 Dec; 20(12):1039-43. PubMed ID: 9466276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-dose busulfan and thiotepa with autologous bone marrow transplantation in childhood malignant brain tumors: a phase II study.
    Kalifa C; Hartmann O; Demeocq F; Vassal G; Couanet D; Terrier-Lacombe MJ; Valteau D; Brugieres L; Lemerle J
    Bone Marrow Transplant; 1992 Apr; 9(4):227-33. PubMed ID: 1534708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-dose thiotepa with autologous bone marrow rescue in pediatric solid tumors.
    Saarinen UM; Hovi L; Mäkipernaa A; Riikonen P
    Bone Marrow Transplant; 1991 Nov; 8(5):369-76. PubMed ID: 1768972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-dose thiotepa and etoposide-based regimens with autologous hematopoietic support for high-risk or recurrent CNS tumors in children and adults.
    Papadopoulos KP; Garvin JH; Fetell M; Vahdat LT; Garrett TJ; Savage DG; Balmaceda C; Bruce J; Sisti M; Isaacson S; De LaPaz R; Hawks R; Bagiella E; Antman KH; Hesdorffer CS
    Bone Marrow Transplant; 1998 Oct; 22(7):661-7. PubMed ID: 9818693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A phase I dose escalation study of high-dose thiotepa, melphalan and carboplatin (TMCb) followed by autologous peripheral blood stem cell transplantation (PBSCT) in patients with solid tumors and hematologic malignancies.
    Demirer T; Ilhan O; Mandel NM; Arat M; Günel N; Celebi H; Ustün C; Akan H; Demirer S; Aydintuğ S; Uysal A; Koç H
    Bone Marrow Transplant; 2000 Apr; 25(7):697-703. PubMed ID: 10745253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topotecan combined with myeloablative doses of thiotepa and carboplatin for neuroblastoma, brain tumors, and other poor-risk solid tumors in children and young adults.
    Kushner BH; Cheung NK; Kramer K; Dunkel IJ; Calleja E; Boulad F
    Bone Marrow Transplant; 2001 Sep; 28(6):551-6. PubMed ID: 11607767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-dose chemotherapy with autologous stem-cell transplantation and hyperfractionated radiotherapy as first-line treatment of primary CNS lymphoma.
    Illerhaus G; Marks R; Ihorst G; Guttenberger R; Ostertag C; Derigs G; Frickhofen N; Feuerhake F; Volk B; Finke J
    J Clin Oncol; 2006 Aug; 24(24):3865-70. PubMed ID: 16864853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Megachemotherapy followed by autologous stem cell transplantation in children with Ewing's sarcoma.
    Drabko K; Zawitkowska-Klaczynska J; Wojcik B; Choma M; Zaucha-Prazmo A; Kowalczyk J; Gorczynska E; Toporski J; Kałwak K; Turkiewicz D; Chybicka A
    Pediatr Transplant; 2005 Oct; 9(5):618-21. PubMed ID: 16176419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thiotepa-based high-dose chemotherapy with autologous stem-cell rescue in patients with recurrent or progressive CNS germ cell tumors.
    Modak S; Gardner S; Dunkel IJ; Balmaceda C; Rosenblum MK; Miller DC; Halpern S; Finlay JL
    J Clin Oncol; 2004 May; 22(10):1934-43. PubMed ID: 15143087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Phase I dose escalation trial of continuous infusion paclitaxel to augment high dose cyclophosphamide and thiotepa plus stem cell rescue for the treatment of patients with advanced breast carcinoma.
    Zimmerman TM; Grinblatt DL; Malloy R; Williams SF
    Cancer; 1998 Oct; 83(8):1540-5. PubMed ID: 9781947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Double-conditioning regimens consisting of thiotepa, melphalan and busulfan with stem cell rescue for the treatment of pediatric solid tumors.
    Hara J; Osugi Y; Ohta H; Matsuda Y; Nakanishi K; Takai K; Fujisaki H; Tokimasa S; Fukuzawa M; Okada A; Okada S
    Bone Marrow Transplant; 1998 Jul; 22(1):7-12. PubMed ID: 9678789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-dose busulfan/melphalan as conditioning for autologous PBPC transplantation in pediatric patients with solid tumors.
    Diaz MA; Vicent MG; Madero L
    Bone Marrow Transplant; 1999 Dec; 24(11):1157-9. PubMed ID: 10642802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outpatient sequential high dose alkylation with stem cell support for patients with advanced breast cancer: a phase I-II study.
    Genre D; Viens P; Gravis G; Bertucci F; Cowen D; Novakovitch G; Derméche S; Chabannon C; Oziel-Taieb S; Camerlo J; Houvenaeghel G; Jacquemier J; Maraninchi D
    Anticancer Res; 2000; 20(3B):2033-40. PubMed ID: 10928147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Combination of high-dose chemotherapy with autologous hematopoietic stem cell transplantation for recurrent and high-risk breast cancer: a pilot study].
    Shi Y; Pan F; Han X
    Zhonghua Yi Xue Za Zhi; 1999 Dec; 79(12):890-3. PubMed ID: 11715500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A feasibility study of multiple cycle therapy with melphalan, thiotepa, and paclitaxel followed by mitoxantrone, thiotepa, and paclitaxel with autologous hematopoietic cell support for metastatic breast cancer.
    Hu WW; Long GD; Stockerl-Goldstein KE; Johnston LJ; Chao NJ; Negrin RS; Blume KG
    Clin Cancer Res; 1999 Nov; 5(11):3411-8. PubMed ID: 10589752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [High-dose chemotherapy with autologous peripheral blood stem cell transplantation (PBSCT) for refractory bone and soft tissue sarcomas].
    Yonemoto T; Tatezaki S; Ishii T; Satoh T
    Gan To Kagaku Ryoho; 1999 Sep; 26(10):1431-5. PubMed ID: 10500530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myeloablative chemotherapy with autologous peripheral blood stem cell transplantation in patients with poor-prognosis solid tumors - Bulgarian experience.
    Avramova B; Jordanova M; Michailov G; Konstantinov D; Christosova I; Bobev D
    J BUON; 2006; 11(4):433-8. PubMed ID: 17309174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Single and double high-dose chemotherapy with autologous stem cell transplantation in children with advanced solid tumors: first experiences].
    Kühne T; Staehelin F; Avoledo P; Tichelli A; Passweg J; Imbach P; Gratwohl A
    Schweiz Med Wochenschr; 2000 Mar; 130(12):419-25. PubMed ID: 10780056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.